|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01558 HEC CJ PHARM
Nominal 
9.350 -0.230 (-2.401%) Ranking Overview
Ranking based on 1 research report(s)
Average Ranking 2.00
|
Strong Buy (1)
0
|
Buy (2)
1
|
Hold (3)
0
|
Sell (4)
0
|
Strong Sell (5)
0
|
Previous Financial Performance
| Financial Year | 12/2023 | EPS | 226.00 RMB (cts) | |
| Net Profit | 1,992.62 RMB (MIL) | DPS | 0.00 RMB (cts) |
Consolidation Estimation
| Financial Year | Profit / (Loss) (RMB (MIL)) |
EPS/ ((LPS)(RMB (cts)) |
DPS (RMB (cts)) |
Net Asset Value per Share (RMB) |
Highest (RMB (MIL)) |
Lowest (RMB (MIL)) |
| 2024 | 1,641.00 | 186.00 | 99.46 | -- | 1,641.00 | 1,641.00 |
| 2025 | 1,771.00 | 201.00 | 87.56 | -- | 1,771.00 | 1,771.00 |
| 2026 | 1,817.00 | 206.00 | 94.36 | -- | 1,817.00 | 1,817.00 |
Profit Estimation
| Profit Estimation | Profit / (Loss) (RMB (MIL)) |
EPS*/ (LPS) (RMB (cts)) |
DPS * (RMB (cts)) |
Broker | Ranking | Target Price* (HKD) |
Update Date | |
| 2024 | 1,641.00 | 186.00 | 99.46 | MORGAN STANLEY | Overweight | 13.80 | 25/11/2024 | |
| 2025 | 1,771.00 | 201.00 | 87.56 | MORGAN STANLEY | -- | -- | 25/11/2024 | |
| 2026 | 1,817.00 | 206.00 | 94.36 | MORGAN STANLEY | -- | -- | 25/11/2024 | |
| Remarks: | Average rating ranges from 1 to 5. The lower the figure, the higher the rating and the vice versa. |
| *EPS, DPS and Estimated Price would be adjusted upon Consolidation, Split and Bonus Issue | |
| Real time quote last updated: 27/12/2024 18:00 | |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 684,731 |
| %Change | -33.489% |
| EPS / (LPS) | RMB 0.780 |
| NBV Per Share (¥) | RMB 9.847 |